肌肠神经元中的胰岛素:在1型糖尿病大鼠中的时间依赖和区域变化
Abigél Egyed-Kolumbán1, Benita Onhausz1, Bence Pál Barta1
1Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.
Cells
|June 11, 2025
概括
肠道神经元中的胰岛素存在随着糖尿病的持续时间和位置而变化. 这可能会保护某些神经元免受糖尿病损伤,为糖尿病神经病变提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病会对肠道神经元造成损伤,影响肠道运动.
- 胰岛素的神经保护作用,包括抑制神经炎症,表明它在神经元生存中起作用.
研究的目的:
- 调查胰岛素在肌肠神经元及其基子群中的存在和分布.
- 检查1型糖尿病急性和慢性大鼠模型中胰岛素免疫反应神经元的变化.
主要方法:
- 从对照,糖尿病和胰岛素治疗的糖尿病大鼠中分析肠道部分和胰腺,1周和10周.
- 免疫组织化学和免疫黄金电子显微镜检测胰岛素.
- 使用分子方法检测胰岛素mRNA.
主要成果:
- 在对照组中,胰岛素免疫反应神经元在阴茎/结肠中占8-9%,在十二指肠中占2-4%.
- 在急性高血糖症 (十二指肠除外) 中比例增加,在慢性高血糖症 (结肠) 中比例降低.
- 胰岛素免疫反应性基神经元在慢性高血糖症中保持不变;在慢性糖尿病十二指腺中观察到金颗粒密度增加.
结论:
- 这些发现支持胰岛素免疫反应神经元的时间依赖性和区域性变化.
- 肌肠神经元中的区域特异性胰岛素含量可能有助于防止糖尿病损伤.
- 在肠道样本中没有检测到胰岛素mRNA,这表明后转录调节或吸收.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Glucagon-like Receptor Agonists
306
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
306
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Insulin Formulations: Types and Delivery
177
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
177
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K


